Lord, Abbett & Co. LLC Eli Lilly & CO Transaction History

Lord, Abbett & Co. LLC

$31.4 Billion
Q3 2024

A detailed history of Lord, Abbett & Co. LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 378,010 shares of LLY stock, worth $301 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares

378,010

Previous 378,010 -0.0%

Holding current value

$301 Million

Previous $335 Million -0.0%

% of portfolio

1.07%

Previous 1.09%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $55.6 Million - $69.1 Million	-71,978 Reduced 16.0%	378,010 $335 Million
Q2 2024 Oct 07, 2024	BUY	$724.87 - $909.04 $25.3 Million - $31.7 Million	34,925 Added 8.41%	449,988 $407 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $25.3 Million - $31.7 Million	34,925 Added 8.41%	449,988 $407 Million
Q1 2024 Oct 07, 2024	SELL	$592.2 - $792.28 $22.5 Million - $30.1 Million	-38,005 Reduced 8.39%	415,063 $323 Million
Q1 2024 May 09, 2024	SELL	$592.2 - $792.28 $22.5 Million - $30.1 Million	-38,005 Reduced 8.39%	415,063 $323 Million
Q4 2023 Oct 07, 2024	SELL	$525.19 - $619.13 $79.7 Million - $94 Million	-151,837 Reduced 25.1%	453,068 $264 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $79.7 Million - $94 Million	-151,837 Reduced 25.1%	453,068 $264 Million
Q3 2023 Oct 07, 2024	SELL	$434.7 - $599.3 $9.47 Million - $13.1 Million	-21,786 Reduced 3.48%	604,905 $325 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $9.47 Million - $13.1 Million	-21,786 Reduced 3.48%	604,905 $325 Million
Q2 2023 Oct 07, 2024	BUY	$350.74 - $468.98 $67.4 Million - $90.2 Million	192,241 Added 44.25%	626,691 $294 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $67.4 Million - $90.2 Million	192,241 Added 44.25%	626,691 $294 Million
Q1 2023 Oct 07, 2024	SELL	$310.63 - $364.82 $136 Million - $160 Million	-439,002 Reduced 50.26%	434,450 $149 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $136 Million - $160 Million	-439,002 Reduced 50.26%	434,450 $149 Million
Q4 2022 Oct 07, 2024	BUY	$321.55 - $374.67 $136 Million - $159 Million	423,464 Added 94.11%	873,452 $320 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $35.6 Million - $41.5 Million	-110,648 Reduced 11.24%	873,452 $320 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $75.3 Million - $85.8 Million	253,940 Added 34.78%	984,100 $318 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $60.8 Million - $71.4 Million	218,147 Added 42.61%	730,160 $237 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $31.3 Million - $38.8 Million	-133,166 Reduced 20.64%	512,013 $147 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $1.42 Million - $1.76 Million	-6,313 Reduced 0.97%	645,179 $178 Million
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $4.56 Million - $5.62 Million	20,592 Added 3.26%	651,492 $151 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $26.6 Million - $34.4 Million	-147,305 Reduced 18.93%	630,900 $145 Million
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $38 Million - $49.2 Million	231,403 Added 42.32%	778,205 $145 Million
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $71.3 Million - $94.4 Million	546,802 New	546,802 $92.3 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $20.2 Million - $23.7 Million	-181,263 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $3.22 Million - $3.6 Million	-30,363 Reduced 14.35%	181,263 $21 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $18.2 Million - $22.7 Million	211,626 New	211,626 $22.7 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account

Lord, Abbett & Co. LLC Eli Lilly & CO Transaction History